Kinsley Hubel

Publications by Year

Research Areas

COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, Respiratory Support and Mechanisms, SARS-CoV-2 and COVID-19 Research, Cardiac Arrest and Resuscitation

Most-Cited Works

• → Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial(2022)127 cited
• → Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022(2022)58 cited
• → Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021(2021)22 cited
• → Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial(2023)19 cited
• → Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial(2023)3 cited
• → 1873: THE SKY’S THE LIMIT: HIGH-DOSE INSULIN FOR CALCIUM CHANNEL BLOCKER OVERDOSE(2016)2 cited
• → Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man(2018)1 cited
• → Protocol and Statistical Analysis Plan for the Pragmatic Trial Examining Oxygenation Prior to Intubation of Preoxygenation With Noninvasive Ventilation vs Oxygen Mask in Critically Ill Adults(2023)1 cited
• → Preliminary Analysis of the Association Between Therapeutic-Dose Anticoagulation and Long Term Outcomes from the ACTIV-4a and ATTACC Multiplatform Adaptive Trial of Hospitalized Patients with COVID-19(2022)1 cited
• → When Rare Meets Deadly: Fulminant Streptococcal Toxic Shock in a Young Patient With Kaposiform Lymphangiomatosis(2025)1 cited